A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time. Those medications, however, are not without their risks and side effects.

A new Northwestern Medicine study publishing in Nature Medicine suggests a promising alternative to previous attempts to ...

Until recently, there was no way to buy them more time. The available drugs for Alzheimer’s could only temporarily ease some symptoms—not change anything about the underlying brain disease.

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...

Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's ...

There has been progress. The latest Alzheimer’s drug appears to tackle the characteristic features of the disease in the ...

Nonsteroidal anti-inflammatory drug use for over 2 years was associated with a lower risk for dementia, especially ...

Researchers are exploring potential new treatment for Alzheimer's disease, inspired by natural compound found in commonly ...

It's been three months since George Henderson – an Army veteran with Alzheimer's disease – was taken to the ground by a ...

The National Institute for Health and Care Excellence (NICE) has decided to reconsult on draft guidance for Alzheimer’s treatments donanemab and lecanemab, six months after initially rejecting the ...

The latest Alzheimer’s drug appears to tackle the characteristic ... “Then we also had one brain treated with one of the newer drugs that is on the market right now,” she said.